|
1.
|
A JemalR SiegelE WardE MurrayT XuMJ
ThunCancer statisticsCA Cancer J Clin5743662007
|
|
2.
|
PC BlackCP DinneyBladder cancer
angiogenesis and metastasis - translation from murine model to
clinical trialCancer Metastasis
Rev26623634200710.1007/s10555-007-9084-917726580
|
|
3.
|
MC MettsJC MettsSJ MilitoCR Thomas
JrBladder cancer: a review of diagnosis and managementJ Natl Med
Assoc92285294200010918764
|
|
4.
|
JM CrawfordThe origins of bladder
cancerLab Invest88686693200810.1038/labinvest.2008.4818475256
|
|
5.
|
NM HeneyK ProppeGR ProutPP GriffinWU
ShipleyInvasive bladder cancer: tumor figuration, lymphatic
invasion and survivalJ Urol13089589719836632095
|
|
6.
|
AP MitraCC BartschRJ CoteStrategies for
molecular expression profiling in bladder cancerCancer Metastasis
Rev28317326200910.1007/s10555-009-9196-519997771
|
|
7.
|
WG Stetler-StevensonS AznavoorianLA
LiottaTumor cell interactions with the extracellular matrix during
invasion and metastasisAnnu Rev Cell
Biol9541573199310.1146/annurev.cb.09.110193.0025458280471
|
|
8.
|
LM MatrisianMetalloproteinases and their
inhibitors in matrix remodelingTrends
Genet6121125199010.1016/0168-9525(90)90126-Q2132731
|
|
9.
|
J WestermarckVM KahariRegulation of matrix
metalloproteinase expression in tumor invasionFASEB
J13781792199910224222
|
|
10.
|
B DaviesJ WaxmanH WasanP AbelG WilliamsT
KrauszD NealD ThomasA HanbyF BalkwillLevels of matrix
metalloproteases in bladder cancer correlate with tumor grade and
invasionCancer Res535365536919938221672
|
|
11.
|
FJ BiancoDC Gervasi JrR TiguertDJ
GrignonJE PontesJD CrissmanR FridmanDP Wood JrMatrix
metalloproteinase-9 expression in bladder washes from bladder
cancer patients predicts pathological stage and gradeClin Cancer
Res43011301619989865914
|
|
12.
|
OR MookWM FrederiksCJ Van NoordenThe role
of gelatinases in colorectal cancer progression and
metastasisBiochim Biophys Acta17056989200415588763
|
|
13.
|
M BondP RosalindP FabunmiAH BakerAC
NewbySynergistic upregulation of metalloproteinase-9 by growth
factors and inflammatory cytokines: an absolute requirement for
transcription factor NF-kappa BFEBS
Lett4352934199810.1016/S0014-5793(98)01034-59755853
|
|
14.
|
H SatoM SeikiRegulatory mechanism of 92
kDa type IV collagenase gene expression which is associated with
invasiveness of tumor cellsOncogene839540519938426746
|
|
15.
|
SK MoonBY ChaCH KimERK1/2 mediates
TNF-alpha-induced matrix metalloproteinase-9 expression in human
vascular smooth muscle cells via the regulation of NF-kappaB and
AP-1: Involvement of the ras dependent pathwayJ Cell
Physiol198417427200410.1002/jcp.1043514755547
|
|
16.
|
S KimJH ChoiHI LimSK LeeWW KimS ChoJS
KimJH KimJH ChoeSJ NamEGF-induced MMP-9 expression is mediated by
the JAK3/ERK pathway, but not by the JAK3/STAT-3 pathway in a SKBR3
breast cancer cell lineCell
Signal21892898200910.1016/j.cellsig.2009.01.03419385051
|
|
17.
|
SV KotenkoG GallagherVV BaurinA
Lewis-AntesM ShenNK ShahJA LangerF SheikhH DickensheetsRP
DonnellyIFN-λs mediate antiviral protection through a distinct
class II cytokine receptor complexNat Immunol469772003
|
|
18.
|
P SheppardW KindsvogelW XuK HendersonS
SchlutsmeyerTE WhitmoreR KuestnerU GarriguesC BirksJ RorabackIL-28,
IL-29 and their class II cytokine receptor IL-28RNat
Immunol46368200310.1038/ni87312469119
|
|
19.
|
S BrandF BeigelT OlszakK ZitzmannST
EichhorstJM OtteJ DieboldH DiepolderB AdlerCJ AuernhammerIL-28A and
IL-29 mediate antiproliferative and antiviral signals in intestinal
epithelial cells and murine CMV infection increases colonic IL-28A
expressionAm J Physiol Gastrointest Liver
Physiol289G960G968200510.1152/ajpgi.00126.2005
|
|
20.
|
L YangY LuoJ WeiS HeIntegrative genomic
analyses on IL28RA, the common receptor of interferon-λ1, -λ2 and
-λ3Int J Mol Med25807812201020372826
|
|
21.
|
A LasfarA Lewis-AntesSV SmirnovS AnanthaW
AbushahbaB TianK ReuhlH DickensheetsF SheikhRP
DonnellyCharacterization of the mouse IFN-λ ligand-receptor system:
IFN-λs exhibit antitumor activity against B16 melanomaCancer
Res66446844772006
|
|
22.
|
M NumasakiM TagawaF IwataT SuzukiA
NakamuraM OkadaY IwakuraS AibaM YamayaIL-28 elicits antitumor
responses against murine fibrosarcomaJ
Immunol17850865098200710.4049/jimmunol.178.8.508617404291
|
|
23.
|
LM CoussensZ WerbInflammation and
cancerNature420860867200210.1038/nature0132212490959
|
|
24.
|
A MantovaniP AllavenaA SicaF
BalkwillCancer-related
inflammationNature454436444200810.1038/nature07205
|
|
25.
|
M OkamotoK HattoriR OyasuInterleukin-6
functions as an autocrine growth factor in human bladder carcinoma
cell lines in vitroInt J
Cancer72149154199710.1002/(SICI)1097-0215(19970703)72:1%3C149::AID-IJC21%3E3.0.CO;2-D9212236
|
|
26.
|
K InoueJW SlatonSJ KimP PerrotteBY EveM
Bar-EliR RadinskyCP DinneyInterleukin 8 expression regulates
tumorigenicity and metastasis in human bladder cancerCancer
Res6022902299200010786697
|
|
27.
|
SJ LeeSS ParkYH ChoK ParkEJ KimKH JungSK
KimWJ KimSK MoonActivation of matrix metalloproteinase-9 by TNF-α
in human urinary bladder cancer HT1376 cells: The role of MAP
kinase signaling pathwaysOncol Rep19100710132008
|
|
28.
|
SJ LeeSS ParkUS LeeWJ KimSK MoonSignaling
pathway for TNF-alpha-induced MMP-9 expression: mediation through
p38 MAP kinase, and inhibition by anti-cancer molecule magnolol in
human urinary bladder cancer 5637 cellsInt
Immunopharmacol818211826200810.1016/j.intimp.2008.08.01818801463
|
